Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease

Ishii Hideki; Aoyama Toru; Takahashi Hiroshi; Kumada Yoshitaka; Kamoi Daisuke; Sakakibara Takashi; Umemoto Norio; Suzuki Susumu; Tanaka Akihito; Ito Yasuhiko; Murohara Toyoaki

首页> 外文期刊>Journal of cardiology >Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease

【24h】

Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease

机译：西洛他唑治疗改善了血液透析患者外周动脉疾病的血管内治疗后的临床疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Cilostazol has been reported to prevent atherosclerotic events in the general population. However, data have been limited whether there are beneficial effects of cilostazol use on long-term clinical outcomes after endovascular therapy in hemodialysis (HD) patients with peripheral artery disease (PAD).

机译：背景：已有报道西洛他唑可预防一般人群的动脉粥样硬化事件。但是，对于在血液透析（HD）伴有外周动脉疾病（PAD）的患者进行血管内治疗后，西洛他唑对长期临床结局是否有有益效果的数据有限。

著录项

来源
《Journal of cardiology》 |2016年第2期|共6页
作者
Ishii Hideki; Aoyama Toru; Takahashi Hiroshi; Kumada Yoshitaka; Kamoi Daisuke; Sakakibara Takashi; Umemoto Norio; Suzuki Susumu; Tanaka Akihito; Ito Yasuhiko; Murohara Toyoaki;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Cilostazol; Hemodialysis; Peripheral artery disease; Stroke; Prognosis;

机译：西洛他唑;血液透析;外周动脉疾病;中风;预后;

相似文献

外文文献
中文文献
专利

1. Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease [J] . Ishii Hideki, Aoyama Toru, Takahashi Hiroshi, Journal of cardiology . 2016,第1a2期

机译：西洛他唑治疗改善了血液透析患者外周动脉疾病的血管内治疗后的临床疗效
2. Effect of the antiplatelet agent cilostazol on endovascular inflammatory biochemical parameters and the clinical symptoms of peripheral artery disease and restless legs syndrome in hemodialysis patients [J] . Shunji Shiohira, Takumi Yoshida, Hidekazu Sugiura, Clinical and Experimental Nephrology . 2011,第6期

机译：抗血小板药西洛他唑对血液透析患者血管内炎性生化指标及周围动脉疾病和不安腿综合征的临床症状的影响
3. Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease. [J] . Ishii H, Kumada Y, Toriyama T, Journal of vascular surgery . 2010,第4期

机译：C反应蛋白水平对血管透析患者外周动脉疾病血管内治疗后临床结局的预后价值。
4. Evaluation of clinical outcomes using exercise test in patients with coronary artery disease after percutaneous coronary intervention [C] . Mintale Iveta, Zabunova Milana, Lurina Dace, International Congress on Coronary Artery Disease . 2009

机译：经皮冠状动脉介入后冠状动脉疾病患者运动试验评估临床结果
5. Clinical outcome of endovascular treatment of carotid artery occlusive disease. [D] . Siewiorek, Gail M. 2010

机译：颈内动脉闭塞性疾病血管内治疗的临床结果。
6. Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study [O] . Paik Seong Lim, Yachung Jeng, Ming Ying Wu, 2006

机译：西洛他唑治疗在无症状性外周动脉疾病血液透析患者中的作用：一项回顾性队列研究
7. Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease [O] . Ishii Hideki, Aoyama Toru, Takahashi Hiroshi, 2016

机译：西洛他唑治疗改善了血液透析患者外周动脉疾病的血管内治疗后的临床疗效

Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease

摘要

著录项

相似文献

相关主题

期刊订阅